The Cardiac Effects of COVID-19 on Young Competitive Athletes: Results from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA)

Author:

Moulson Nathaniel1,Petek Bradley J.23,Baggish Aaron L.45,Harmon Kimberly G.6,Kliethermes Stephanie A.7,Patel Manesh R.8,Churchill Timothy W.23,Drezner Jonathan A.6ORCID

Affiliation:

1. Division of Cardiology and Sports Cardiology BC, University of British Columbia, Vancouver, BC V6T2B5, Canada

2. Massachusetts General Hospital Division of Cardiology, Boston, MA 02114, USA

3. Cardiovascular Performance Program, Boston, MA 02114, USA

4. Department of Cardiology, Lausanne University Hospital (CHUV), CH-105 Lausanne, Switzerland

5. Institute for Sport Science, University of Lausanne (ISSUL), CH-105 Lausanne, Switzerland

6. Department of Family Medicine and Center for Sports Cardiology, University of Washington, Seattle, WA 98195, USA

7. Department of Orthopedics and Rehabilitation, University of Wisconsin Madison, Madison, WI 53705, USA

8. Division of Cardiology, Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27710, USA

Abstract

The Outcomes Registry for Cardiac Conditions in Athletes (ORCCA) study is a large-scale prospective investigation evaluating the cardiovascular effects and outcomes of SARS-CoV-2 infection on young competitive athletes. This review provides an overview of the key results from the ORCCA study. Results from the ORCCA study have provided important insights into the clinical impact of SARS-CoV-2 infection on the cardiovascular health of young competitive athletes and informed contemporary screening and return to sport practices. Key results include defining a low prevalence of both cardiac involvement and adverse cardiovascular outcomes after SARS-CoV-2 infection and evaluating the utility of a return-to-play cardiac evaluation. Future aims of the ORCCA study include the longer-term evaluation of cardiovascular outcomes among athletes post-SARS-CoV-2 infection and the transition to investigating outcomes in young athletes with potentially high-risk genetic or structural cardiac diagnoses.

Funder

American Medical Society for Sports Medicine (AMSSM) Foundation

AMSSM Collaborative Research Network

American Heart Association

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference40 articles.

1. Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., and Zhao, Q. (2020). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol.

2. Acute Myocardial Injury at Hospital Admission Is Associated With All-Cause Mortality in COVID-19;Ni;J. Am. Coll. Cardiol.,2020

3. COVID-19 and Cardiovascular Disease;Clerkin;Circulation,2020

4. (2021, October 27). American Medical Society for Sports Medicine and the American College of Cardiology. Cardiac Considerations for College Student-Athletes during the COVID-19 Pandemic. Available online: https://www.amssm.org/Content/pdf-files/COVID19/NCAA_COVID-18-AUG-2021.pdf.

5. Resurgence of sport in the wake of COVID-19: Cardiac considerations in competitive athletes;Baggish;Br. J. Sports Med.,2020

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3